These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 6096585
21. [A case of penicillin-resistant pneumococcal meningitis and antibiotic susceptibility of Streptococcus pneumoniae isolated from children]. Himi K, Miyamoto S, Ohshimi H, Kuroki H, Ishikawa N, Yamazaki T, Namba M, Suzuki H, Uehara S, Niimi H. Kansenshogaku Zasshi; 1990 Jun; 64(6):725-33. PubMed ID: 2401818 [Abstract] [Full Text] [Related]
22. [Evaluation of in vitro antibacterial potencies of oral antibiotics against sputum isolates]. Yamada H, Nakanishi H, Yamaguchi M, Nagasawa Z. Jpn J Antibiot; 1983 Aug; 36(8):2103-8. PubMed ID: 6361322 [Abstract] [Full Text] [Related]
23. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ. Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733 [Abstract] [Full Text] [Related]
24. Cefotaxime and desacetylcefotaxime in neonates and children: a review of microbiologic, pharmacokinetic, and clinical experience. Jacobs RF, Kearns GL. Diagn Microbiol Infect Dis; 1989 Oct; 12(1):93-9. PubMed ID: 2653717 [Abstract] [Full Text] [Related]
25. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)]. Ikemoto H, Watanabe K, Kosakai N, Hayashi Y, Oguri T, Saito A, Shinohara M, Matsumiya H, Ueda K, Ida S. Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915 [Abstract] [Full Text] [Related]
26. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N. Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430 [Abstract] [Full Text] [Related]
27. [In vitro activity and clinical evaluation of ceftriaxone in the field of obstetrics and gynecology]. Ninomiya K, Yoshimoto T, Hasegawa Y. Jpn J Antibiot; 1984 Dec; 37(12):2349-54. PubMed ID: 6098728 [Abstract] [Full Text] [Related]
28. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children. Goldwater PN. Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469 [Abstract] [Full Text] [Related]
29. Antibiotic concentrations in liquor compared to the minimal inhibitory concentrations of isolates in paediatric bacterial meningitis. The Finnish Study Group. Ellmén JK, Renkonen OV, Anttila MA, Peltola HO. Chemotherapy; 1991 Nov; 37(1):1-5. PubMed ID: 1901543 [Abstract] [Full Text] [Related]
30. The change of susceptibility of Streptococcus pneumoniae strains isolated from pediatric patients at Asahikawa Kosei Hospital between 2011 and 2015. Sakata H. Jpn J Antibiot; 2016 Dec; 69(6):367-372. PubMed ID: 30226931 [Abstract] [Full Text] [Related]
31. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kondou T, Kobayashi K, Satou K, Matsumiya H, Saito A. Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326 [Abstract] [Full Text] [Related]
32. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci. Jones RN, Barry AL, Packer RR. Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217 [Abstract] [Full Text] [Related]
33. [Fundamental and clinical studies on cefminox in the field of pediatrics]. Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M. Jpn J Antibiot; 1985 Mar; 38(3):705-19. PubMed ID: 3897604 [Abstract] [Full Text] [Related]
34. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Matsuda M, Tanimoto H, Nakata K, Nakamori Y, Kusano N. Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860 [Abstract] [Full Text] [Related]
35. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test. Reller LB. Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219 [Abstract] [Full Text] [Related]
36. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams. Schrinner E, Limbert M, Seeger K, Seibert G, Novick WJ. Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214 [Abstract] [Full Text] [Related]
37. [Bacteriological, pharmacokinetic and clinical studies on the use of ceftriaxone in the perinatal period]. Cho N, Fukunaga K, Kunii K, Deguchi K. Jpn J Antibiot; 1988 Feb; 41(2):180-95. PubMed ID: 3286925 [Abstract] [Full Text] [Related]
38. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics]. Matsuo K, Uete T. Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908 [Abstract] [Full Text] [Related]
39. [Successful treatment of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b meningitis with high-dose ceftriaxone administration]. Sudo F, Nakamura A, Hoshino T, Ishiwada N, Kohno Y. Kansenshogaku Zasshi; 2004 Jul; 78(7):604-8. PubMed ID: 15359893 [Abstract] [Full Text] [Related]
40. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)]. Shimada K, Nakano K, Ohno I, Okada S, Hayashi K, Yokouchi H, Arakawa M, Gejyo F, Igarashi K, Ikemoto H, Mori T, Okada M, Ozaki K, Igari J, Aoki N, Oguri T, Kitamura N, Terai T, Suzuki Y, Inoue H, Nakadate T, Karasawa Y, Ito C, Yoshida T, Nakata K, Nakatani T, Inagawa H, Ando M, Suga M, Sato K, Kudo K, Kobayashi N, Tosaka M, Hasegawa M, Kohno S, Tomono K, Miyazaki Y, Kobayashi H, Kawai S, Takayasu S, Hirakata Y, Matsuda J, Mochida C, Ito A, Sumitomo M, Nasu M, Nagai H, Matsushima T, Niki Y, Hiramatsu K, Nakano T. Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]